Humer Franz B 4
4 · Allogene Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Humer Franz B
Director
Transactions
- Award
Common Stock
2024-06-05+61,475→ 316,728 total - Award
Stock Option (Right to buy)
2024-06-05+95,541→ 95,541 totalExercise: $2.44Exp: 2034-06-05→ Common Stock (95,541 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly installments